ENFOQUS

Serial Number 88783012
606

Registration Progress

Application Filed
Feb 3, 2020
Under Examination
Mar 2, 2021
Approved for Publication
Jan 5, 2021
Published for Opposition
Jan 5, 2021
Registered

Trademark Image

ENFOQUS

Basic Information

Serial Number
88783012
Filing Date
February 3, 2020
Published for Opposition
January 5, 2021
Abandonment Date
April 8, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 8, 2024
Classes
005

Rights Holder

Cingulate Therapeutics LLC

16
Address
1901 W 47th Place, Suite 310
Kansas City, KS 66205

Ownership History

Cingulate Therapeutics LLC

Original Applicant
16
Kansas City, KS

Cingulate Therapeutics LLC

Owner at Publication
16
Kansas City, KS

Legal Representation

Attorney
Susan Neuberger Weller

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

44 events
Date Code Type Description Documents
Apr 8, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Apr 8, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Sep 8, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 7, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Sep 7, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 28, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Aug 28, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 16, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 14, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 14, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Feb 14, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 17, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 25, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 23, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 23, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 23, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 24, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 22, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 22, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 22, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 20, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 20, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 20, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 8, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 4, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 4, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 4, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 2, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 5, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 5, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 16, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 2, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 23, 2020 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Nov 23, 2020 ALIE A ASSIGNED TO LIE Loading...
Apr 21, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 21, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 21, 2020 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Apr 21, 2020 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Apr 21, 2020 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Apr 21, 2020 CNSL R SUSPENSION LETTER WRITTEN Loading...
Apr 21, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 20, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 6, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 6, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)

Classification

International Classes
005